nordihydroguiaretic acid   Click here for help

GtoPdb Ligand ID: 4265

Abbreviated name: NDGA
Synonyms: Actinex®
Approved drug
nordihydroguiaretic acid is an approved drug (FDA (1992))
Compound class: Natural product
Comment: Although we show the non-isomeric molecule, the approved drug masoprocol is a specific stereoisomer of NGDA, with IUPAC name 4-[(2S,3R)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol (as shown in the PubChem record). The ChEMBL record displays the non-stereoisomeric molecule. PubChem lists 6 stereoisomers of this compound.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 0
Hydrogen bond donors 4
Rotatable bonds 5
Topological polar surface area 80.92
Molecular weight 302.15
XLogP 5.49
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C(Cc1ccc(c(c1)O)O)C)Cc1ccc(c(c1)O)O
Isomeric SMILES CC(C(Cc1ccc(c(c1)O)O)C)Cc1ccc(c(c1)O)O
InChI InChI=1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3
InChI Key HCZKYJDFEPMADG-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Used in the treatment of actinic keratoses. The US FDA has discontinued approval for masoprocol.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The exact mechanism of action of masoprocol is unknown, but it is a potent inhibitor of 5-lipoxygenase and has antiproliferative activity against keratinocytes in vitro.